conivaptan has been researched along with Infarction, Middle Cerebral Artery in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elliott, JP; Jones, SM; Zeynalov, E | 2 |
| Collier, L; Decker, D; Lau, T; Leonardo, C; Olivera, R; Pennypacker, KR; Roma, G; Rowe, D; Seifert, H | 1 |
3 other study(ies) available for conivaptan and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Therapeutic time window for conivaptan treatment against stroke-evoked brain edema and blood-brain barrier disruption in mice.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blood-Brain Barrier; Brain Edema; Infarction, Middle Cerebral Artery; Male; Mice; Mice, Inbred C57BL | 2017 |
The Effects of Clinically Relevant Hypertonic Saline and Conivaptan Administration on Ischemic Stroke.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Brain; Brain Edema; Disease Models, Animal; Fluoresceins; Fluorescent Dyes; Immunohistochemistry; Infarction, Middle Cerebral Artery; Laser-Doppler Flowmetry; Macrophage Activation; Male; Microglia; Rats; Rats, Sprague-Dawley; Saline Solution, Hypertonic | 2016 |
Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Brain Edema; Disease Models, Animal; Infarction, Middle Cerebral Artery; Infusions, Intravenous; Male; Mice; Mice, Inbred C57BL; Random Allocation; Receptors, Vasopressin; Stroke | 2016 |